Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › KY › LOUISVILLE › UNIVERSITY MEDICAL CENTER, INC

UNIVERSITY MEDICAL CENTER, INC

NPI: 1861554438 · LOUISVILLE, KY 40202 · Student in an Organized Health Care Education/Training Program · NPI assigned 12/13/2006

$179.41M
Total Medicaid Paid
2,408,658
Total Claims
1,745,405
Beneficiaries
492
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSTRACK, KIRK (CFO)
NPI Enumeration Date12/13/2006

Related Entities

Other providers sharing the same authorized official: STRACK, KIRK

ProviderCityStateTotal Paid
UOFL HEALTH-LOUISVILLE INC LOUISVILLE KY $283.15M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 317,093 $18.78M
2019 329,175 $20.40M
2020 338,504 $24.00M
2021 374,946 $28.27M
2022 384,561 $33.12M
2023 377,713 $31.44M
2024 286,666 $23.39M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 59,377 40,921 $27.91M
J9271 Injection, pembrolizumab, 1 mg 2,925 1,950 $19.23M
99284 Emergency department visit for the evaluation and management, high severity 55,498 45,059 $12.18M
99283 Emergency department visit for the evaluation and management, moderate severity 65,422 52,788 $8.54M
74177 Computed tomography, abdomen and pelvis; with contrast material 15,495 12,955 $6.17M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 16,751 8,149 $6.10M
J9299 Injection, nivolumab, 1 mg 981 482 $4.16M
96375 Therapeutic injection; each additional sequential IV push 28,092 17,997 $3.44M
99282 Emergency department visit for the evaluation and management, low to moderate severity 34,244 27,166 $3.17M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 16,203 8,413 $2.94M
70450 Computed tomography, head or brain; without contrast material 19,279 16,090 $2.87M
77386 4,349 378 $2.69M
71260 Computed tomography, thorax, diagnostic; with contrast material 11,252 9,759 $2.67M
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 2,204 1,768 $2.55M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 59,798 43,693 $2.34M
96417 3,663 2,049 $2.21M
72125 Computed tomography, cervical spine; without contrast material 11,969 9,870 $2.20M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 34,795 23,020 $2.01M
G0378 Hospital observation service, per hour 42,739 20,587 $1.97M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 3,271 2,820 $1.88M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1,324 1,021 $1.86M
80053 Comprehensive metabolic panel 136,134 90,023 $1.76M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,502 1,140 $1.75M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 42,283 32,399 $1.52M
96415 3,862 2,484 $1.34M
96361 Intravenous infusion, hydration; each additional hour 33,379 19,203 $1.21M
71045 Radiologic examination, chest; single view 27,261 20,606 $1.15M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 19,181 15,412 $1.11M
J0585 Injection, onabotulinumtoxina, 1 unit 1,730 1,450 $1.11M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 5,604 3,652 $1.03M
78815 Positron emission tomography (PET) for limited area imaging 952 816 $999K
71046 Radiologic examination, chest; 2 views 16,934 13,599 $939K
74176 Computed tomography, abdomen and pelvis; without contrast material 2,777 2,265 $907K
70551 Magnetic resonance imaging, brain; without contrast material 2,094 1,820 $903K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 131,277 92,298 $897K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 24,455 7,824 $827K
70486 4,948 4,364 $825K
88305 Level IV - Surgical pathology, gross and microscopic examination 8,920 7,373 $778K
58571 570 304 $777K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2,530 2,215 $774K
J2350 Injection, ocrelizumab, 1 mg 44 36 $731K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 27,068 17,004 $693K
87631 6,560 5,902 $661K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 33,267 22,916 $652K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 859 591 $650K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 14,904 8,464 $641K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 18,344 13,857 $633K
76705 Ultrasound, abdominal, real time with image documentation; limited 5,583 4,874 $624K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg 556 497 $604K
70498 2,081 1,822 $592K
77336 4,159 1,513 $576K
99281 Emergency department visit for the evaluation and management, self-limited or minor 11,796 9,737 $565K
96367 4,811 1,892 $564K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 490 364 $537K
59025 Fetal non-stress test 6,695 4,968 $532K
93308 3,067 2,684 $522K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 351 299 $469K
73030 6,376 5,108 $469K
36224 101 61 $467K
96368 2,307 1,331 $442K
36415 Collection of venous blood by venipuncture 105,823 61,084 $430K
97530 Therapeutic activities, direct patient contact, each 15 minutes 11,929 4,146 $409K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 8,236 6,474 $406K
73630 6,167 5,055 $399K
77067 Screening mammography, bilateral, including computer-aided detection 8,475 8,203 $392K
70496 1,254 959 $382K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 2,631 2,276 $374K
71250 1,696 1,435 $370K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 9,136 8,125 $369K
93975 1,967 1,785 $369K
93971 1,799 1,585 $365K
70491 1,340 1,077 $364K
73610 7,376 5,959 $351K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 22,105 19,569 $349K
73590 6,434 5,157 $345K
73552 4,797 3,875 $341K
J2469 Injection, palonosetron hcl, 25 mcg 4,355 2,386 $338K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg 192 66 $327K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 126 108 $317K
73564 5,248 4,174 $315K
96411 1,419 832 $312K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 5,501 4,129 $297K
73130 5,876 4,786 $289K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 5,848 2,425 $284K
77300 1,107 485 $280K
73560 4,001 3,101 $275K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 935 809 $273K
76770 2,194 1,857 $271K
J2704 Injection, propofol, 10 mg 21,081 15,180 $264K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 10,236 8,981 $260K
82947 39,982 26,213 $259K
76830 Ultrasound, transvaginal 976 860 $242K
77334 958 585 $239K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 5,910 3,830 $238K
93970 817 711 $234K
J1756 Injection, iron sucrose, 1 mg 3,416 1,276 $232K
84484 22,444 16,327 $228K
88307 1,953 1,572 $226K
J1453 Injection, fosaprepitant, 1 mg 818 503 $223K
36226 57 49 $222K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 457 400 $219K
76700 Ultrasound, abdominal, real time with image documentation; complete 1,442 1,213 $217K
73110 4,677 3,815 $210K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 495 365 $203K
87522 Neg quan hep c or qual rna 6,755 5,985 $199K
76642 2,706 2,321 $197K
87634 6,485 5,870 $191K
86803 20,205 17,856 $182K
76000 2,912 2,438 $180K
J1200 Injection, diphenhydramine hcl, up to 50 mg 10,536 7,449 $177K
36430 887 515 $174K
73090 3,914 3,170 $171K
J0185 Injection, aprepitant, 1 mg 809 505 $169K
73060 2,890 2,301 $167K
20680 156 118 $163K
73502 3,576 2,981 $161K
81268 952 772 $161K
J3010 Injection, fentanyl citrate, 0.1 mg 23,321 19,057 $159K
84443 Thyroid stimulating hormone (TSH) 11,657 9,455 $159K
90715 6,404 5,629 $155K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 7,243 6,126 $153K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 18,338 12,758 $150K
73080 2,672 2,272 $147K
86850 16,061 13,149 $146K
97161 3,022 2,565 $146K
72131 850 769 $145K
72170 2,407 1,935 $143K
97162 3,668 2,774 $143K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 1,185 947 $139K
88341 1,020 834 $138K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 248 150 $134K
87902 731 647 $134K
77063 Screening digital breast tomosynthesis, bilateral 5,827 5,112 $134K
80048 Basic metabolic panel (calcium, ionized) 19,613 12,163 $133K
99153 Mod sedat endo service >5yrs 1,581 1,428 $132K
72100 1,760 1,509 $131K
J7050 Infusion, normal saline solution, 250 cc 10,089 5,380 $131K
72190 1,074 959 $129K
83690 28,265 24,055 $129K
J1170 Injection, hydromorphone, up to 4 mg 17,658 12,110 $126K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4,513 4,118 $125K
81001 32,859 28,017 $123K
J2405 Injection, ondansetron hydrochloride, per 1 mg 28,684 21,929 $121K
36591 2,712 1,970 $120K
83880 4,478 3,512 $112K
96376 4,516 3,519 $112K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 490 438 $111K
43235 175 111 $111K
77066 Tomosynthesis, mammo 2,308 1,841 $110K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 402 343 $109K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 3,901 3,323 $108K
84702 11,047 9,078 $104K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 12,214 6,283 $103K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 11,607 8,995 $103K
C1769 Guide wire 427 316 $101K
85610 27,129 22,034 $100K
84703 15,906 13,808 $98K
91200 1,705 1,524 $97K
64642 861 400 $97K
97166 2,029 1,696 $95K
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion 587 325 $95K
76536 742 659 $95K
88342 1,790 1,521 $94K
96402 1,528 1,154 $94K
73562 1,347 1,047 $93K
J3490 Unclassified drugs 11,198 3,779 $92K
83735 18,035 9,762 $92K
88185 555 388 $91K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 906 781 $91K
64488 167 140 $90K
10060 834 714 $89K
85730 21,376 17,804 $87K
J7120 Ringers lactate infusion, up to 1000 cc 7,835 6,001 $86K
J0690 Injection, cefazolin sodium, 500 mg 10,644 7,442 $85K
J2250 Injection, midazolam hydrochloride, per 1 mg 22,782 18,964 $84K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 4,292 1,751 $83K
72141 261 219 $82K
74018 1,963 1,647 $82K
82805 1,621 1,265 $81K
87808 8,122 7,304 $80K
J1885 Injection, ketorolac tromethamine, per 15 mg 19,087 15,923 $79K
64643 508 336 $78K
36561 60 52 $77K
36227 18 12 $76K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 5,993 5,280 $74K
73700 362 298 $73K
87905 8,199 7,373 $72K
J1650 Injection, enoxaparin sodium, 10 mg 5,685 2,428 $70K
12002 973 887 $68K
97165 1,307 1,144 $67K
99152 2,656 2,371 $67K
77065 Tomosynthesis, mammo 1,990 1,501 $64K
87040 4,914 3,319 $63K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,342 2,891 $62K
80074 1,802 1,596 $61K
97022 4,257 1,468 $60K
97116 2,436 1,436 $60K
97602 1,407 768 $59K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,661 2,365 $58K
86900 16,029 13,159 $56K
81003 22,042 18,422 $56K
64494 99 78 $56K
76604 515 457 $55K
82565 4,953 3,814 $55K
97168 1,606 1,512 $55K
85027 10,644 8,506 $53K
J0897 Injection, denosumab, 1 mg 28 24 $53K
86920 810 682 $53K
P9016 Red blood cells, leukocytes reduced, each unit 400 278 $53K
77301 29 25 $53K
72128 263 248 $53K
J0640 Injection, leucovorin calcium, per 50 mg 881 344 $52K
82728 4,706 3,700 $52K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 413 382 $52K
A9573 Injection, gadopiclenol, 1 ml 971 735 $49K
82607 4,536 3,753 $49K
83605 5,700 4,580 $48K
64493 131 94 $47K
86901 15,977 13,158 $47K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 2,942 2,465 $47K
J0696 Injection, ceftriaxone sodium, per 250 mg 6,296 5,149 $45K
88304 1,019 895 $45K
J9190 Injection, fluorouracil, 500 mg 1,299 395 $45K
J1644 Injection, heparin sodium, per 1000 units 5,011 2,639 $44K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 2,561 2,120 $43K
J0780 Injection, prochlorperazine, up to 10 mg 2,409 2,039 $42K
80061 Lipid panel 3,271 2,341 $42K
J2270 Injection, morphine sulfate, up to 10 mg 8,882 6,296 $42K
J2795 Injection, ropivacaine hydrochloride, 1 mg 3,590 2,881 $42K
84100 12,985 7,162 $42K
12001 739 674 $40K
J2370 Injection, phenylephrine hcl, up to 1 ml 2,957 2,032 $40K
87086 Culture, bacterial; quantitative colony count, urine 6,719 5,668 $40K
84153 2,196 1,786 $39K
87070 3,070 2,493 $39K
74183 57 52 $39K
87075 4,866 4,314 $39K
82550 7,183 5,199 $37K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,458 1,360 $37K
70487 143 116 $37K
J3480 Injection, potassium chloride, per 2 meq 2,367 1,511 $36K
86780 3,277 2,771 $35K
87210 7,944 7,160 $35K
J3475 Injection, magnesium sulfate, per 500 mg 4,014 2,734 $34K
77080 530 455 $34K
72040 539 452 $33K
41899 Unlisted procedure, dentoalveolar structures 53 42 $33K
87077 3,906 3,427 $32K
82553 3,220 2,167 $32K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 2,351 1,512 $31K
97535 Self-care/home management training, each 15 minutes 1,531 986 $31K
V2790 Amniotic membrane for surgical reconstruction, per procedure 16 14 $30K
73070 700 552 $29K
76870 259 223 $29K
J3370 Injection, vancomycin hcl, 500 mg 2,021 1,290 $29K
82746 2,690 2,337 $28K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 11,422 7,425 $28K
84466 3,102 2,617 $27K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,499 1,964 $27K
88309 193 161 $27K
J9045 Injection, carboplatin, 50 mg 831 395 $26K
J1953 Injection, levetiracetam, 10 mg 1,268 947 $26K
J7030 Infusion, normal saline solution , 1000 cc 2,520 1,746 $25K
J1815 Injection, insulin, per 5 units 2,764 836 $25K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,112 842 $24K
C1760 Closure device, vascular (implantable/insertable) 131 114 $24K
83036 Hemoglobin; glycosylated (A1C) 3,622 3,236 $24K
82378 1,526 1,205 $23K
77001 329 279 $23K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 118 63 $23K
J1790 Injection, droperidol, up to 5 mg 3,339 2,846 $23K
12011 354 312 $22K
84439 2,223 1,837 $21K
72156 48 38 $21K
76937 182 157 $21K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 50 39 $21K
88184 575 391 $21K
86923 436 310 $20K
96523 1,112 773 $20K
J0330 Injection, succinylcholine chloride, up to 20 mg 1,754 1,277 $20K
83615 4,283 3,156 $19K
86140 5,149 4,396 $19K
76942 54 53 $19K
J2060 Injection, lorazepam, 2 mg 4,625 3,743 $19K
83520 1,157 832 $19K
J7060 5% dextrose/water (500 ml = 1 unit) 1,477 613 $19K
36600 708 555 $19K
86790 1,790 1,533 $18K
85379 2,590 2,334 $18K
87340 2,477 2,165 $18K
94760 3,850 2,244 $18K
87186 2,035 1,769 $18K
64450 30 24 $17K
73600 453 332 $17K
83540 3,352 2,817 $17K
76882 211 176 $17K
94644 484 412 $17K
97760 681 622 $17K
86334 911 676 $16K
86704 1,751 1,531 $16K
J2560 Injection, phenobarbital sodium, up to 120 mg 267 238 $16K
74178 30 27 $16K
J9267 Injection, paclitaxel, 1 mg 527 224 $16K
70480 90 80 $15K
80164 1,649 1,256 $15K
86706 1,924 1,725 $15K
77338 63 50 $15K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,628 1,446 $15K
85652 4,974 4,326 $14K
77290 104 39 $14K
95874 1,066 929 $14K
71101 219 208 $13K
80047 1,361 1,056 $13K
64495 33 26 $13K
87205 2,586 2,168 $13K
G0297 Low dose ct scan (ldct) for lung cancer screening 54 54 $13K
86480 243 226 $13K
84165 1,214 928 $12K
87653 388 359 $12K
19083 12 12 $11K
93017 87 79 $11K
L3808 Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment 151 101 $11K
V2632 Posterior chamber intraocular lens 179 131 $11K
J1630 Injection, haloperidol, up to 5 mg 3,481 2,870 $11K
82105 910 788 $10K
74019 225 209 $10K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 307 155 $9K
82803 738 577 $9K
64644 61 37 $9K
88108 536 407 $9K
86038 715 639 $8K
C9113 Injection, pantoprazole sodium, per vial 1,187 742 $8K
71271 65 57 $8K
20694 13 12 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 236 215 $8K
82570 1,812 1,549 $8K
73000 159 143 $8K
97035 499 192 $7K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 167 137 $7K
88313 186 153 $7K
J0561 Injection, penicillin g benzathine, 100,000 units 27 25 $7K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 68 27 $7K
J3411 Injection, thiamine hcl, 100 mg 618 268 $7K
97016 380 135 $7K
96409 35 13 $6K
76001 30 28 $6K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 28 26 $6K
80178 989 749 $6K
88331 131 97 $6K
97763 248 204 $6K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 39 34 $5K
84156 1,952 1,627 $5K
85384 746 558 $5K
97018 330 157 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 306 250 $5K
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 522 276 $5K
J3360 Injection, diazepam, up to 5 mg 276 216 $5K
84166 243 154 $5K
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg 21 12 $4K
73565 81 77 $4K
83721 436 421 $4K
83970 109 100 $4K
87102 607 499 $4K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 634 452 $4K
82784 216 189 $4K
J2310 Injection, naloxone hydrochloride, per 1 mg 163 116 $4K
84550 889 730 $4K
86705 368 347 $3K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 171 87 $3K
87428 72 59 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 17 14 $3K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 267 206 $3K
83550 1,794 1,545 $3K
C1874 Stent, coated/covered, with delivery system 69 58 $3K
41800 47 45 $3K
91065 13 13 $3K
86235 39 38 $3K
96416 25 15 $3K
C1788 Port, indwelling (implantable) 14 13 $3K
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml 75 66 $3K
85048 536 338 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 5,603 4,832 $3K
73620 60 37 $2K
93320 38 24 $2K
97597 37 24 $2K
86328 150 115 $2K
G0008 Administration of influenza virus vaccine 142 129 $2K
64616 22 12 $2K
86146 51 51 $2K
82150 502 435 $2K
85014 1,616 1,293 $2K
87015 526 274 $2K
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 552 448 $2K
87116 382 316 $2K
86147 59 51 $2K
97164 99 89 $2K
87517 64 61 $2K
29125 55 38 $2K
73140 85 71 $2K
77370 14 12 $2K
J2997 Injection, alteplase recombinant, 1 mg 13 12 $2K
85045 593 423 $2K
J1171 Injection, hydromorphone, 0.1 mg 339 233 $2K
87641 88 76 $2K
J1596 Injection, glycopyrrolate, 0.1 mg 335 282 $2K
A4648 Tissue marker, implantable, any type, each 15 13 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 604 527 $2K
72070 26 24 $2K
88302 55 49 $2K
J8540 Dexamethasone, oral, 0.25 mg 1,036 891 $2K
J9263 Injection, oxaliplatin, 0.5 mg 45 24 $1K
93356 13 13 $1K
0001A 69 49 $1K
J3489 Injection, zoledronic acid, 1 mg 83 76 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg 164 133 $1K
J2550 Injection, promethazine hcl, up to 50 mg 752 628 $1K
86160 39 39 $1K
J9060 Injection, cisplatin, powder or solution, 10 mg 80 28 $1K
86922 13 12 $1K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 143 122 $1K
87081 157 146 $966.32
87206 351 291 $952.20
84145 62 56 $931.79
85049 355 243 $927.03
88173 60 48 $914.24
J3486 Injection, ziprasidone mesylate, 10 mg 14 12 $837.20
J2175 Injection, meperidine hydrochloride, per 100 mg 297 270 $828.47
77417 28 12 $811.84
86200 44 44 $779.53
0031A 27 22 $722.36
89051 114 74 $657.34
90686 249 203 $624.22
83010 82 65 $622.30
90674 76 64 $580.90
J1920 Injection, labetalol hydrochloride, 5 mg 72 53 $542.43
J1805 Injection, esmolol hydrochloride, 10 mg 81 68 $530.95
99426 15 14 $516.58
J0735 Injection, clonidine hydrochloride, 1 mg 38 38 $497.05
88311 48 41 $490.20
94010 16 12 $470.80
J2765 Injection, metoclopramide hcl, up to 10 mg 143 122 $435.41
95700 16 14 $410.23
J1956 Injection, levofloxacin, 250 mg 31 26 $340.17
73100 16 14 $336.29
82248 76 55 $331.27
82140 41 38 $306.27
82010 55 45 $304.60
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 243 169 $304.48
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing 19 12 $302.00
82247 58 43 $295.58
86255 46 44 $290.32
87640 14 13 $285.97
86787 36 27 $277.77
97150 Therapeutic procedure(s), group (2 or more individuals) 20 14 $271.46
86141 45 42 $257.69
83497 25 24 $243.23
J2359 Injection, olanzapine, 0.5 mg 17 12 $235.73
97139 39 25 $234.64
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 114 53 $205.52
85018 62 38 $201.93
J0670 Injection, mepivacaine hydrochloride, per 10 ml 32 26 $196.89
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 13 13 $187.70
51798 18 12 $185.01
87556 17 13 $180.02
J1580 Injection, garamycin, gentamicin, up to 80 mg 14 12 $173.71
87147 52 42 $166.08
12013 15 14 $164.16
J0360 Injection, hydralazine hcl, up to 20 mg 28 24 $157.49
86709 14 14 $155.20
86376 13 13 $143.34
87449 19 13 $134.06
A9270 Non-covered item or service 1,946 461 $133.60
L3931 Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment 93 88 $132.66
J2780 Injection, ranitidine hydrochloride, 25 mg 33 32 $132.13
82525 20 13 $124.92
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 14 13 $82.16
86431 17 16 $72.35
J1836 Injection, metronidazole, 10 mg 18 14 $69.26
82945 12 12 $48.50
84157 12 12 $45.30
Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 59 48 $29.14
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 36 28 $25.20
80341 12 12 $14.83
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 24 14 $10.03
Q0244 Injection, casirivimab and imdevimab, 1200 mg 18 12 $0.15
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 44 39 $0.07
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 14 12 $0.00
91300 157 117 $0.00
80334 12 12 $0.00
80326 12 12 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 24 13 $0.00
80331 12 12 $0.00